United States · FDA National Drug Code directory
Avance Nerve Graft
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84545-130_5c0c36c2-0dcf-4762-8653-31805880f668
- Product NDC
- 84545-130
- Form
- IMPLANT
- Composition / generic term
- Processed nerve allograft
- Labeler
- Axogen Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260406
- Source listing expiry
- 20271231
Source-listed ingredients
- HUMAN PERIPHERAL NERVE TISSUE — 1 mm/30mm
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTON in 1 BAG (84545-130-01) / 1 POUCH in 1 CARTON / 1 POUCH in 1 POUCH / 1 CONTAINER in 1 POUCH / 1 mm in 1 CONTAINER · 84545-130-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →